INCON Announces Massive 7.41 Million Share Third-Party Allotment, Raising 8 Billion KRW for New Office, Dilution Exceeds 47%

INCON disclosed a third-party allotment of 7,414,273 common shares at 1,079 KRW per share to raise 8 billion KRW for facility investment.
The total outstanding shares will increase by approximately 47.7% from 15.54 million to 22.96 million, causing significant dilution for existing shareholders.
The issuance price is a 10% discount from the reference price of 1,198 KRW, with a one-year mandatory holding period for the new shares.
Upon completion, the largest shareholder will change from K-Bio Labs to Mirae I&G Co., Ltd.
The proceeds will be used to purchase a new office building and related costs, with the investment period from Q3 2026 to Q4 2027.
[AI Summary]This capital increase results in extreme dilution of nearly 48% and introduces management uncertainty due to the change in controlling shareholder. The stock price is likely to face downward pressure in the short term, and the success of the office investment in improving profitability remains to be seen. Investors should carefully monitor the dilution risk and governance shift.